YOUNG PHILIP M 4

What Happened

• Philip M. Young, a member of Carlsmed’s Board of Directors, was granted 13,698 restricted stock units (RSUs) on June 3, 2026. The Form 4 reports the award as 13,698 shares at $0.00 (an RSU grant, not an open-market purchase).
• The RSUs convert 1-for-1 into shares of common stock upon vesting and carry no immediate cash payment. This is an award (transaction code A), not a sale or purchase.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-22 (more than the standard 2-business-day reporting window).
• Grant size: 13,698 RSUs; reported price: $0.00 (reflects an award, not a cash purchase).
• Vesting: RSUs vest in full on the earlier of (i) the day before the issuer’s 2027 annual meeting of stockholders or (ii) June 3, 2027, subject to Young’s continued service on the Board (footnote F1).
• Holdings/control notes: Footnotes indicate shares are also held by PMY Partners L.P. and the Young Family Trust; Young is sole general partner of PMY Partners L.P. and a trustee of the Trust with voting and dispositive power over those holdings (F2–F5).
• Shares owned after the transaction: not specified in the excerpted filing.

Context

• RSU grants to directors are a common form of compensation and typically reflect retention/compensation rather than a public market signal. These RSUs will become actual shares only upon vesting, assuming continued board service.
• The Form 4 was filed roughly 19 days after the grant date, which is later than the standard 2-business-day reporting requirement; investors may want to note the timing but should not infer motive from timing alone.